B.Riley Financial Reaffirms Their Buy Rating on Altimmune (ALT)
B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Altimmune (ALT – Research Report) yesterday and set a price target of ...
The Mining Journal7h
RHI Magnesita completes Resco purchase
Refractory producer RHI Magnesita has completed its $410 million acquisition of US-based Resco Group, expanding its reach in ...